Pegdarbepoetin beta - Biocad
Alternative Names: BCD-131; PEG-Darbepoetin; Pegylated darbepoetin - Biocad; Pegylated darbepoetin alpha - Biocad; Pegylated darbepoetin beta - BiocadLatest Information Update: 10 Mar 2021
Price :
$50 *
At a glance
- Originator Biocad
- Class Antianaemics; Polyethylene glycols; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaemia
Most Recent Events
- 10 Mar 2021 No development reported - Phase-II for Anaemia in Belarus (SC)
- 10 Mar 2021 No development reported - Phase-II for Anaemia in Russia (SC)
- 24 Oct 2017 Phase-II clinical trials in Anaemia in Belarus, Russia (SC) (NCT03519243)